Catalyst Wire Dossier Catalyst Wire Dossier

ARBLI

Losartan Potassium · Scienture LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ARBLI, covering 2025-03-13 to 2026-02-18. Get the full timeline:

Most recent: FDA Approved: ARBLI — Supplemental Application (Scienture LLC)

See pricing